PredictrPK® IFX Maintenance
Use
The IFX Maintenance test predicts infliximab trough levels and calculates clearance to guide the optimization of dosing strategies in IBD patients. This aims to maintain stable therapeutic levels over time and improve the durability of biologic response.
Special Instructions
Not provided.
Limitations
As a non-FDA approved laboratory-developed test, the results should be integrated cautiously into clinical decision-making. Inter-patient variability in drug metabolism may not be fully encompassed by test parameters.
Methodology
Immunoassay (Proteomic Panel)
Biomarkers
Result Turnaround Time
3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2.0 mL
Minimum Volume
Not provided
Container
Serum Separator Tube or Red-Top Tube
Collection Instructions
Collect sample ≤3 days before week 14 or ≥20 days after IFX maintenance infusion.
Storage Instructions
Ambient or cold pack. Do not freeze.
Causes for Rejection
Unlabeled specimens; incorrect tube type
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
Other tests from different labs that may be relevant